Matches in Nanopublications for { ?s ?p "[CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P < 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP62614.RAeC6V4wT5cKTQEc_3eWFW7ET0BCKlQ_oXlkbzfaHQsRg130_assertion description "[CCR5 59029G promoter variant was associated with clearance of HBV infection in an acute phase (OR = 1.71, P = 0.006, dominant model; OR = 2.17, P < 0.001, recessive model) and amelioration of hepatic inflammation (P = 0.003) with the control of HBV replication (P = 0.04) in chronic carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62614.RAeC6V4wT5cKTQEc_3eWFW7ET0BCKlQ_oXlkbzfaHQsRg130_provenance.